Jason Adam Zell

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5153
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and Liver Cancer (CLOVER)
    NIH R61AG068948Aug 15, 2020 - Jul 31, 2022
    Role: Co-Principal Investigator
    Risk reduction through polyamine inhibition among colorectal carcinoma patients
    NIH K23CA133142Aug 20, 2009 - Jul 31, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms. Cancers (Basel). 2022 May 16; 14(10). Devico Marciano N, Kroening G, Dayyani F, Zell JA, Lee FC, Cho M, Valerin JG. PMID: 35626055.
      View in: PubMed   Mentions:
    2. Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review. Oncologist. 2022 03 11; 27(3):210-219. Juat DJ, Hachey SJ, Billimek J, Del Rosario MP, Nelson EL, Hughes CCW, Zell JA. PMID: 35274719; PMCID: PMC8914488.
      View in: PubMed   Mentions:
    3. Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol. Clin Colorectal Cancer. 2021 Nov 28. Jafari MD, Carmichael JC, Dayyani F, McKinney C, Wenzel L, Zell JA, Pigazzi A. PMID: 34980534.
      View in: PubMed   Mentions:
    4. Surgical Management of Gynecologic Cancers. Surg Oncol Clin N Am. 2021 01; 30(1):69-88. Clair KH, Wolford J, Zell JA, Bristow RE. PMID: 33220810.
      View in: PubMed   Mentions: 1     Fields:    
    5. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol. 2020 12; 17(12):757-770. Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster H, Hong TS, Innocenti F, Iqbal A, Jacobs SA, Kennecke HF, Lee JJ, Lieu CH, Lenz HJ, Lindwasser OW, Montagut C, Odisio B, Ou FS, Porter L, Raghav K, Schrag D, Scott AJ, Shi Q, Strickler JH, Venook A, Yaeger R, Yothers G, You YN, Zell JA, Kopetz S. PMID: 32632268; PMCID: PMC7790747.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    6. Increased incidence of early onset colorectal adenocarcinoma is accompanied by an increased incidence of rectal neuroendocrine tumors. Am J Cancer Res. 2020; 10(6):1888-1899. Lumsdaine CT, Liu-Smith F, Li X, Zell JA, Lu Y. PMID: 32642298; PMCID: PMC7339271.
      View in: PubMed   Mentions:
    7. Changing Disparity of Gastric Cancer Incidence by Histological Types in US Race-Specific Populations. Cancer Control. 2020 Jan-Dec; 27(1):1073274820977152. Zhu X, Pigazzi A, Zell J, Lu Y. PMID: 33297759; PMCID: PMC8480345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prev Res (Phila). 2020 02; 13(2):203-212. Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL. PMID: 31818851; PMCID: PMC8025666.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    9. Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response. Surg Oncol. 2020 Mar; 32:35-40. Gahagan JV, Whealon MD, Phelan MJ, Mills S, Jafari MD, Carmichael JC, Stamos MJ, Zell JA, Pigazzi A. PMID: 31726418.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. An ultrasensitive test for profiling circulating tumor DNA using integrated comprehensive droplet digital detection. Lab Chip. 2019 03 13; 19(6):993-1005. Ou CY, Vu T, Grunwald JT, Toledano M, Zimak J, Toosky M, Shen B, Zell JA, Gratton E, Abram TJ, Zhao W. PMID: 30735225; PMCID: PMC6559803.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    11. The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis. J Carcinog. 2017; 16:3. Tran PN, Taylor TH, Klempner SJ, Zell JA. PMID: 28974922; PMCID: PMC5615860.
      View in: PubMed   Mentions: 7  
    12. Information needs of oncologists, general practitioners and other professionals caring for patients with cancer. Eur J Cancer Care (Engl). 2016 Nov; 25(6):1015-1023. Ciarlo G, Liebl P, Zell J, Fessler J, Koester MJ, Ruetters D, Mugele K, Huebner J. PMID: 27550233.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Trends in colorectal cancer admissions and stage at presentation: impact of screening. Surg Endosc. 2016 08; 30(8):3604-10. Moghadamyeghaneh Z, Alizadeh RF, Phelan M, Carmichael JC, Mills S, Pigazzi A, Zell JA, Stamos MJ. PMID: 26541735; PMCID: PMC5691213.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Digital quantification of miRNA directly in plasma using integrated comprehensive droplet digital detection. Lab Chip. 2015 Nov 07; 15(21):4217-26. Zhang K, Kang DK, Ali MM, Liu L, Labanieh L, Lu M, Riazifar H, Nguyen TN, Zell JA, Digman MA, Gratton E, Li J, Zhao W. PMID: 26387763; PMCID: PMC4631652.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    15. PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas. Bull Am Coll Surg. 2015 Aug; 100(8):70-1. Zell J, You YN, Boughey JC. PMID: 26419059.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum. Cancer Prev Res (Phila). 2015 Mar; 8(3):222-30. Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM. PMID: 25604134; PMCID: PMC4355051.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    17. Colorectal Cancer Incidence Among Young Adults in California. J Adolesc Young Adult Oncol. 2014 Dec 01; 3(4):176-184. Singh KE, Taylor TH, Pan CG, Stamos MJ, Zell JA. PMID: 25538862; PMCID: PMC4270106.
      View in: PubMed   Mentions: 24     Fields:    
    18. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Lupus. 2015 Feb; 24(2):203-9. Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J. PMID: 25267076; PMCID: PMC4465250.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    19. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis. J Gastrointest Surg. 2014 Mar; 18(3):592-8. Tsang WY, Ziogas A, Lin BS, Seery TE, Karnes W, Stamos MJ, Zell JA. PMID: 24297651; PMCID: PMC4035039.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br J Cancer. 2013 Feb 19; 108(3):512-8. Raj KP, Zell JA, Rock CL, McLaren CE, Zoumas-Morse C, Gerner EW, Meyskens FL. PMID: 23340449; PMCID: PMC3593561.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    21. Everolimus causing severe hypertriglyceridemia and acute pancreatitis. J Natl Compr Canc Netw. 2013 Jan 01; 11(1):5-9. Subramaniam S, Zell JA, Kunz PL. PMID: 23307976.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer. J Gastrointest Surg. 2013 Feb; 17(2):374-81. Seery TE, Ziogas A, Lin BS, Pan CJ, Stamos MJ, Zell JA. PMID: 23242847; PMCID: PMC3551443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis. J Carcinog. 2012; 11:17. Zell JA, Lin BS, Ziogas A, Anton-Culver H. PMID: 23233821; PMCID: PMC3516190.
      View in: PubMed   Mentions: 2  
    24. Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas. Cancer Causes Control. 2012 Oct; 23(10):1739-44. Zell JA, Lin BS, Madson N, McLaren CE, Gerner EW, Meyskens FL. PMID: 22907422; PMCID: PMC3443348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer. Expert Rev Gastroenterol Hepatol. 2012 Aug; 6(4):507-17. Rial NS, Zell JA, Cohen AM, Gerner EW. PMID: 22928902; PMCID: PMC3587976.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Population-based evaluation of adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum. 2012 May; 55(5):509-14. Masoomi H, Ziogas A, Lin BS, Barleben A, Mills S, Stamos MJ, Zell JA. PMID: 22513428; PMCID: PMC3330249.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    27. Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. J Bone Joint Surg Am. 2012 Feb 15; 94(4):356-63. Lee J, Bhatia NN, Hoang BH, Ziogas A, Zell JA. PMID: 22336975; PMCID: PMC6882537.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer. Dis Colon Rectum. 2011 May; 54(5):526-34. Pan CJ, Ziogas A, Buchberg B, Raj KP, Mills SD, Stamos MJ, Zell JA. PMID: 21471752.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Phase IIA trial testing erlotinib as an intervention against intraductal pancreatic mucinous neoplasms. Cancer Prev Res (Phila). 2011 Apr; 4(4):512-3. Lipkin S, Lee J, Imagawa D, Hewitt SM, Tucker C, Zell JA, Wong V, Garcia A, Gonzalez R, Della Zanna G, Richmond E, Rodriguez LM, Bigg M, Schnoll-Sussmans F, Meyskens F. PMID: 21464031; PMCID: PMC4492452.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    30. Clinical trials update: Tertiary prevention of colorectal cancer. J Carcinog. 2011 Mar 24; 10:8. Zell JA. PMID: 21483656; PMCID: PMC3072658.
      View in: PubMed   Mentions: 2  
    31. Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysis. J Carcinog. 2011 Mar 17; 10:6. Raj KP, Taylor TH, Wray C, Stamos MJ, Zell JA. PMID: 21483654; PMCID: PMC3072650.
      View in: PubMed   Mentions: 13  
    32. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Feb; 20(2):389-96. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. PMID: 21217087; PMCID: PMC4110060.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg. 2011 Jan; 15(1):165-74. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. PMID: 21082275; PMCID: PMC3023036.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    34. Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst. 2010 Oct 06; 102(19):1513-6. Zell JA, McLaren CE, Chen WP, Thompson PA, Gerner EW, Meyskens FL. PMID: 20798393; PMCID: PMC2950167.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    35. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era. J Thorac Oncol. 2010 Aug; 5(8):1185-96. Ahn MJ, Lee J, Park YH, Ahn JS, Ziogas A, Zell JA, Park K, Ou SH. PMID: 20592628.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    36. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol. 2010 Jul; 5(7):1001-10. Kawaguchi T, Matsumura A, Fukai S, Tamura A, Saito R, Zell JA, Maruyama Y, Ziogas A, Kawahara M, Ignatius Ou SH. PMID: 20526205.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    37. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila). 2010 Jul; 3(7):865-75. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H. PMID: 20551290; PMCID: PMC2931369.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma. Gastroenterology. 2010 Sep; 139(3):797-805, 805.e1. Thompson PA, Wertheim BC, Zell JA, Chen WP, McLaren CE, LaFleur BJ, Meyskens FL, Gerner EW. PMID: 20538001; PMCID: PMC3399666.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    39. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010 Oct; 21(10):1615-24. Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H. PMID: 20526803; PMCID: PMC2941047.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. 2010 Apr 15; 116(8):1964-73. Lee J, Hoang BH, Ziogas A, Zell JA. PMID: 20151425.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    41. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung. J Thorac Oncol. 2010 Apr; 5(4):420-7. Ou SH, Ziogas A, Zell JA. PMID: 20130484.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status. J Thorac Oncol. 2010 Feb; 5(2):158-68. Ou SH, Ziogas A, Zell JA. PMID: 20040896.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    43. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. Cancer. 2009 Dec 15; 115(24):5662-71. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H. PMID: 19827153; PMCID: PMC3008399.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    44. Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction. BMC Med. 2009 Oct 19; 7:61. Timberlake DS, Zell JA. PMID: 19840371; PMCID: PMC2771035.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    45. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol. 2009 Oct; 4(10):1202-11. Ou SH, Zell JA. PMID: 19701111.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    46. Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Clin Cancer Res. 2009 Oct 01; 15(19):6208-16. Zell JA, Ziogas A, Ignatenko N, Honda J, Qu N, Bobbs AS, Neuhausen SL, Gerner EW, Anton-Culver H. PMID: 19789310; PMCID: PMC2769500.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    47. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol. 2009 Sep; 4(9):1083-93. Ou SH, Ziogas A, Zell JA. PMID: 19652625.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    48. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum. 2009 Aug; 52(8):1359-66. Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA. PMID: 19617745.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    49. Survival prognostication in non-small cell lung cancer. J Thorac Oncol. 2009 Jul; 4(7):785-6. Zell JA, Ignatius Ou SH. PMID: 19550241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. The effect of tumor size on non-size-based descriptors in staging of stage I non-small cell lung cancer. Chest. 2009 Jun; 135(6):1695-1696. Ou SI, Zell JA. PMID: 19497911.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer. Anticancer Drugs. 2009 Apr; 20(4):301-4. Raj KP, Sanati H, Mehta RS, Zell JA. PMID: 19247177.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila). 2009 Mar; 2(3):209-12. Zell JA, Pelot D, Chen WP, McLaren CE, Gerner EW, Meyskens FL. PMID: 19258540; PMCID: PMC2739681.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    53. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition. J Thorac Oncol. 2009 Mar; 4(3):300-10. Ignatius Ou SH, Zell JA. PMID: 19156001.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    54. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res. 2009; 11(1):R9. Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H. PMID: 19228416; PMCID: PMC2687713.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    55. Survival of distinct Asian groups among colorectal cancer cases in California. Cancer. 2009 Jan 15; 115(2):259-70. Le H, Ziogas A, Taylor TH, Lipkin SM, Zell JA. PMID: 19109815; PMCID: PMC4042844.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol. 2009 Jan; 4(1):37-43. Ou SH, Ziogas A, Zell JA. PMID: 19096304.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    57. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3134-40. Zell JA, Honda J, Ziogas A, Anton-Culver H. PMID: 18990755; PMCID: PMC2739671.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    58. A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2737-41. Le H, Ziogas A, Rhee JM, Lee JG, Lipkin SM, Zell JA. PMID: 18843017.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    59. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer. J Thorac Oncol. 2008 Aug; 3(8):880-6. Ou SH, Zell JA. PMID: 18670306.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    60. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):1950-62. Le H, Ziogas A, Lipkin SM, Zell JA. PMID: 18708384.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    61. Identification of HDM2 as a regulator of VEGF expression in cancer cells. Life Sci. 2008 Jun 20; 82(25-26):1231-41. Narasimhan M, Rose R, Ramakrishnan R, Zell JA, Rathinavelu A. PMID: 18504050.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    62. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer. 2008 May 01; 112(9):2011-20. Ou SH, Zell JA, Ziogas A, Anton-Culver H. PMID: 18361399.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    63. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol. 2008 Mar; 3(3):216-27. Ou SH, Zell JA. PMID: 18317063.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    64. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 01; 26(1):66-75. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. PMID: 18165642.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    65. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Cancer. 2008 Jan 01; 112(1):136-43. Zell JA, Ou SH, Ziogas A, Anton-Culver H. PMID: 17960795.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    66. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol. 2007 Dec; 2(12):1078-85. Zell JA, Ignatius Ou SH, Ziogas A, Anton-Culver H. PMID: 18090578.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    67. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest. 2008 Mar; 133(3):662-9. Ou SH, Zell JA, Ziogas A, Anton-Culver H. PMID: 17925418.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    68. Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer. 2007 Oct 01; 110(7):1532-41. Ou SH, Zell JA, Ziogas A, Anton-Culver H. PMID: 17702091.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    69. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007 Jul; 132(1):193-9. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. PMID: 17505036.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    70. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):546-52. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. PMID: 17372250.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    71. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer. 2007 Feb 01; 120(3):459-68. Zell JA, Ignatenko NA, Yerushalmi HF, Ziogas A, Besselsen DG, Gerner EW, Anton-Culver H. PMID: 17096347.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    72. Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer. 2007; 59(1):36-45. Zell JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H. PMID: 17927500.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. Misclassification of bronchioloalveolar carcinoma with cytologic diagnosis of lung cancer. J Thorac Oncol. 2006 Nov; 1(9):943-8. Raz DJ, Zell JA, Karnezis AN, Odisho A, Ignatius Ou SH, Anton-Culver H, Jablons DM. PMID: 17409976; PMCID: PMC5497593.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007 Jan; 18(1):29-35. Ou SI, Zell JA, Ziogas A, Anton-Culver H. PMID: 17060483.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    75. An unusual case of renal carcinoma. Pathology. 2006 Aug; 38(4):370-1. Zell JA, Iyer PR, Kukes GD, Beamon DB. PMID: 16916734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol. 2006 Aug; 17(8):1255-62. Zell JA, Ou SH, Ziogas A, Anton-Culver H. PMID: 16766595.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005 Nov 20; 23(33):8396-405. Zell JA, Ou SH, Ziogas A, Anton-Culver H. PMID: 16293870.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    78. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients. Coron Artery Dis. 2005 May; 16(3):153-61. Bokhari SW, Bokhari ZW, Zell JA, Lee DW, Faxon DP. PMID: 15818084.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer. 2005 Nov; 13(11):870-7. Zell JA, Chang JC. PMID: 15864658.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Anticancer Drugs. 2005 Jan; 16(1):83-5. Zell JA, Yoon EJ, Ignatius Ou SH, Hoefs JC, Chang JC. PMID: 15613909.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    81. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol. 2003 Nov 15; 92(10):1246-9. Canetti M, Akhter MW, Lerman A, Karaalp IS, Zell JA, Singh H, Mehra A, Elkayam U. PMID: 14609613.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    82. Regulation of mdm2 mRNA expression in human breast tumor-derived GI-101A cells. Life Sci. 2002 Oct 04; 71(20):2331-9. Zell JA, Ramakrishnan R, Rathinavelu A. PMID: 12231395.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    83. Laparoscopic diagnosis and repair of asymptomatic bilateral inguinal hernias. Am J Surg. 2002 Jan; 183(1):15-9. O'Rourke A, Zell JA, Varkey-Zell TT, Barone JL, Bayona M. PMID: 11869696.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    84. Expression of vascular endothelial growth factor mRNA in GI-101A and HL-60 cell lines. Biochem Biophys Res Commun. 2000 Apr 21; 270(3):709-13. Ramakrishnan R, Zell JA, Malavé A, Rathinavelu A. PMID: 10772888.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    Jason's Networks
    Concepts (340)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (38)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California